Lupin’s ProAir Rival Has 'Moved Ahead' Despite CRL
Executive Summary
Lupin is staring at stretched launch timelines in the US for its generic ProAir following a Complete Response Letter, but the company maintains that its application has progressed and the market opportunity for the product remains attractive.